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Previewsmast-cell-deficient mice exhibited
reduced early clearance of bacteria in
oral infection with DsptP S. Typhimurium.
The defensive role of mast cells identified
by this study is in line with these cells’
strategic locations in the lamina propria,
where mast cells should have a good
chance of facing invading bacteria before
the bacteria reach mesenteric lymph no-
des and the spleen. Use of a protein tyro-
sine phosphatase with T3SS to block
mast cell degranulation was also shown
in another Gram-negative bacterium Yer-
sinia pestis, which has the homologous
phosphatase YopH.
This study has certainly made a
major step forward in our under-
standing of mast cell interactions with
S. Typhimurium. However, much remains
to be learned. A question of immediate
interest is how mast cells recognize
S. Typhimurium (or mediators released
from infected cells). The authors note
that DsptP S. Typhimurium enhances
Syk phosphorylation induced by stimula-
tion with IgE and anti-IgE, suggesting
that without SptP, Salmonella might
directly activate mast cells. In this regard,
a recent study has shown that the
absence of TLR11 renders mice more
susceptible to S. Typhimurium (Mathur
et al., 2012). Regardless of direct or indi-998 Immunity 39, December 12, 2013 ª2013rect mast cell activation, exposure to
DsptP S. Typhimurium appears to involve
the phosphorylation of Syk. Another
question is related to what the range of
SptP targets is and how dephosphoryla-
tion of the target proteins leads to bio-
logical outcomes such as blockade of
degranulation. Although the current study
shows a clear reduction in tyrosine phos-
phorylation of Syk and NSF in SptP-ex-
pressing cells compared to control cells,
rigorous enzymatic characterization of
SptP-mediated dephosphorylation will
be required for claiming that these mole-
cules are its direct targets. Interestingly,
SptP has a GTPase-activating protein
(GAP) domain involved in the recovery of
cytoskeleton after Salmonella invasion
(Fu and Gala´n, 1999). These observations
suggest that the target proteins of phos-
phatase and GAP activities might be pre-
sent in proximal subcellular locations or
alternatively that the phosphatase activity
works early and GAP activity follows in a
temporally and spatially different manner.
YopH targets remain to be explored.
Another interesting point is what effect
SptP might have in gut epithelial cells
andmacrophages, where S. Typhimurium
can replicate.
In summary, the current study reveals
an effective means adopted by S. Typhi-Elsevier Inc.murium to avoid an innate immune de-
fense mechanism by targeting the central
signaling mechanism of tyrosine phos-
phorylation to shut down mast cells.REFERENCES
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Innate sensing of HIV is important in host control and pathogenesis. In this issue of Immunity, Lahaye et al.
(2013) demonstrate that HIV capsid-cyclophilin A interactions affect viral cDNA sensing by the DNA sensor
cCAS and contribute to differential pathogenesis of HIV-1 and HIV-2.Innate immune system sensing of HIV
infection plays a role in multiple aspects
of HIV pathology, including control
of infection and killing of CD4+ T cells.
This sensing occurs in productively in-
fected cells, nonpermissive resting CD4+
T cells, and other cells like macrophagesand dendritic cells (DCs). The HIV-1 re-
striction factor SAMHD1 is highly ex-
pressed in DCs and resting CD4+ T cells
and interferes with reverse transcription
by reducing dNTP amounts, rendering
these cells resistant to infection (Baldauf
et al., 2012, Goldstone et al., 2011, Lagu-ette et al., 2011). HIV-2 encodes Vpx, an
accessory protein that promotes the
degradation of SAMHD-1, allowing both
HIV-2 infection of DCs and innate sensing
of virus in the DCs that might limit HIV-2
pathogenesis (Figure 1) (Baldauf et al.,
2012). Manel et al. (2010) previously
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Figure 1. Interactions of HIV-1 and HIV-2 with DC
HIV-2 infection of DCs. DCs can be infected with HIV-2 because the HIV-2 Vpx protein, which is present in the virion, promotes degradation of the host restriction
factor SAMHD1. Following reverse transcription, viral cDNA is detected in the cytoplasm by the DNA sensor cGAS. Activated cGAS synthesizes the second
messenger cGAMP, which activates the STING pathway, leading to DC activation and a type I IFN response. DCs are not infected by HIV-1. HIV-1 lacks Vpx
and therefore cannot counteract the restriction factor SAMHD1. SAMHD1 lowers dNTP amounts and thereby inhibits reverse transcription of viral RNA into
cDNA. DC can be infected in experimental situations where Vpx is provided. The infection can be sensed through an incompletely understood postintegration
mechanism that depends on the interaction of newly synthesized capsid proteinwithCpA (Manel et al., 2010). EngineeredHIV variantswithmutations in the capsid
protein that enhance CpA binding (termed HIVac-1 and HIVac-2) are blocked in replication at a preintegration stage, but viral cDNA can be sensed by cGAS.
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Previewsshowed that when DC resistance to HIV-1
infection is circumvented by coinfection
with HIV-2 or Vpx delivery via other mech-
anisms, HIV-1 induces an antiviral type I
interferon response and DC maturation.
This response is dependent on interaction
of HIV-1 capsid with the cellular peptidyl-
prolyl isomerase cyclophilin A (CypA), an
interaction that also promotes infectivity.
The interaction with CypA induces a
capsid conformation change that alters
viral uncoating. This could in turn affect
the ability of intracellular sensors to detect
the viral nucleic acid that serves as a
pathogen-associated molecular pattern
(PAMP).
In this issue of Immunity, Lahaye et al.
(2013) exploit mutations affecting capsid
affinity for CypA to examine the role of
capsid in sensing, to identify the viral
PAMP for DC sensing, and to dissociate
sensing from productive infection given
that both are affected by capsid-CypA in-
teractions. HIV-1 and HIV-2 capsid muta-
tions that increased affinity for CypA
blocked infection of DCs, but allowed
sensing, even for HIV-1, demonstrating
that DCs are competent for innate sensing
in the absence of productive infection.
Capsid-mutated HIV-1 (termed HIVac)
was only sensed if Vpx were present. To
determine whether viral genetic material
is required for sensing, Lahaye et al.
used mutations that reduced viral
genomic RNA encapsidation. DC sensing
was dramatically reduced, demonstratingthat normal encapsidation of the genomic
RNA is required for sensing. Manel et al.
(2010) demonstrated previously that HIV-
1 is sensed in the presence of Vpx only af-
ter integration. Lahaye et al. (2013) used
combinations of HIV mutations and anti-
HIV drugs that block reverse transcription,
nuclear entry, and integration to demon-
strate that HIV-2 is sensed in the cytosol
before integration and that production of
viral cDNA is required. Mutation of the
HIV-2 capsid to enhance CypA binding
did not affect sensing. In contrast, muta-
tion of the HIV-1 capsid to resemble the
high CpA binding HIV-2 mutant allowed
sensing, demonstrating that DCs have
the intrinsic capacity to sense HIV-1 DNA
and that capsid structure is important in
determining where sensing occurs.
The authors then performed genetic
targeting of known DNA sensors DDX41,
IF116, and cyclic GMP-AMP synthase
(cGAS) and demonstrated that the DC
sensor in this system is cGAS. Consistent
with these results, Gao et al. (2013)
recently showed that cGAS senses HIV-1
DNA in the cytosol of a human monocytic
cell line. Cytosolic DNA triggers cGAS to
produce cyclic GMP-AMP (cGAMP),
which binds and activates STING, leading
to activation of the transcription factor
IRF3 and the production of interferon-b
(IFN-b) (Sun et al., 2013).
After entry, the mature viral capsid
uncoats, and viral RNA is reverse tran-
scribed into cDNA which then integratesImmunity 39, Dinto cellular DNA. The studies cited
above suggest that capsid protein struc-
ture and interactions with CpA determine
whether these steps can take place
before the cDNA is sensed by the innate
immune system or rendered noninfec-
tious by other processes.
Given that HIV-1 activation of DC innate
sensing is abrogated in natural HIV-1
infection by SAMHD1 and by structural
features of its capsid, Lahaye et al. sug-
gest that activation of innate sensing
might be employed to enhance control
of HIV-1 in vaccine design or therapeuti-
cally. However, innate immune activation
is a double-edged sword. Immune activa-
tion is the hallmark of HIV-1 pathogenesis,
and there is increasing evidence that
innate sensing might play a role in that
(Deeks et al., 2013).
Activation of innate immune responses
to HIV-1 has different outcomes depend-
ing on the cell type. Doitsh et al. (2010)
recently used a human lymphoid aggre-
gate culture system to demonstrate that
CD4+ T cell death following HIV-1 infec-
tion results in large part from abortive
infection of nonpermissive resting CD4+
T cells. They demonstrated that the accu-
mulation of reverse-transcribed DNA in
these nonpermissive cells elicits a suicidal
cellular response, aswell as inflammation.
Infected cultures produced IFN-b and
high amounts of the proinflammatory
interleukin-1b (IL-1b). The inflammatory
response was completely prevented byecember 12, 2013 ª2013 Elsevier Inc. 999
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Previewsthe reverse trancriptase inhibitor efavirenz
and by AMD3100, a drug that blocks HIV-
1 entry via the HIV-1 coreceptor CXCR4.
This suggests that the inflammatory
response to abortive HIV-1 infection is
triggered by premature termination of viral
DNA elongation, which signals caspase-1
and inflammasome activation and the
maturation and release of bioactive IL-1b
in these CD4+ T cells. Capsase-1 and
inflammasome activation are required
for IL-1b production in this system. There-
fore, caspase-1-dependent cell death,
known as pyroptosis, is a plausible mech-
anism of CD4 depletion.
DNA damage cascades also play a role
in death of activated CD4+ T cells that are
infected with HIV-1. Cooper et al. (2013)
demonstrated that virus-induced CD4+
T cell killing is triggered by integra-
tion. Cell death in this system was asso-
ciated with productive rather than abor-
tive infection. The mechanism of killing
following viral integration involved the
activation of DNA-dependent protein
kinase (DNA-PK), a central integrator of
the DNA damage response, which causes1000 Immunity 39, December 12, 2013 ª201phosphorylation of p53 and histone
H2AX.
Taken together, these studies high-
light the emerging complexity of innate
sensing of HIV-1, with multiple pathways
in different cell types leading to a variety
of outcomes. Lahaye and colleagues
speculate that enhancing innate sensing
might represent a strategy for enhancing
HIV-1 control and producing more effec-
tive vaccines. However, manipulation of
the innate sensing systems might also
result in increased pathogenesis. There-
fore, additional studies in this area
would be of significant value, particularly
in systems that allow interaction between
CD4+ T cells and other immune system
cells so that the total effects of such
manipulations on all cell types and
the overall immune response can be
determined.
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Activation of the complement system has long been known to be regulated by a series of steps involving fluid-
phase convertases. In this issue of Immunity, Liszewski et al. (2013) report the discovery of an intracellular
cathepsin-L-dependent C3 activation pathway.The complement system can be activated
by ‘‘hard-wired’’ pattern-recognition re-
ceptors (PRRs) that have evolved to
recognize pattern-associated molecular
patterns (PAMPs). PRRs in the comple-
ment system recognize exogenous and
endogenous ‘‘danger’’ motifs. Recogni-
tion receptors in the complement system
(i.e., specific antibody, mannan-binding
lectin [MBL], C1q, and natural immuno-
globulin M [IgM]) activate three separate
complement pathways referred to as the
classical, lectin, and alternative. Althougheach of these pathways is activated by
distinct PRRs, they all culminate in activa-
tion of the complement factor 3 (C3), the
central step in complement activation.
The C3 convertase (C3bBb) converts
the inactive yet abundant C3 component
into the biologically active effector frag-
ments referred to as anaphylatoxins
(C3a and C3b). C3a in turn binds its
G-protein-coupled receptor, C3aR, on
the surface of cells, whereas C3b can
either bind its receptor, CD46, or bind to
more of the C3 convertase, creating theC5 convertase [C3(H2O)BbP3b], which
leads to the generation of C5a and C5b.
C5b initiates the terminal enzymatic
cascade of the lytic membrane attack
complex, which mediates lysis of patho-
gens and unprotected host cells.
Although liver-generated circulating
anaphylatoxins undoubtedly play a
role in pathogen control systemically,
emerging evidence suggests that ana-
phylatoxins are also produced by immune
cells, including T cells. Once produced,
they bind their receptors on the T cell
